FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Costantino

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Reena S Cecchini; Joseph P Costantino; Walter M Cronin; Joel L Weissfeld; D Lawrence Wickerham; Hanna Bandos; Jane A Cauley; Norman Wolmark
Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).
Gong Tang; Chung-Chou Ho Chang; Lan Kong; Yuan Kong; Joseph P Costantino
Prediction of accrual closure date in multi-center clinical trials with discrete-time Poisson process models.
Alexander H G Paterson; Edith A Perez; Andre Robidoux; Sandra M Swain; Lorna M Weir; Ping Zheng; Stewart J Anderson; Luis Baez-Diaz; Adam M Brufsky; Joseph P Costantino; Shaker Dakhil; Carla I Falkson; Louis Fehrenbacher; Charles E Geyer; Julie R Gralow; Karen M King; Thomas Lad; Barry C Lembersky; Eleftherios P Mamounas; Norman Wolmark
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Costantino (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Reena S Cecchini; Joseph P Costantino; Walter M Cronin; Joel L Weissfeld; D Lawrence Wickerham; Hanna Bandos; Jane A Cauley; Norman Wolmark
Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).
Cancer prevention research (Philadelphia, Pa.) 2012;5(11):1321-9.
2012: Gong Tang; Chung-Chou Ho Chang; Lan Kong; Yuan Kong; Joseph P Costantino
Prediction of accrual closure date in multi-center clinical trials with discrete-time Poisson process models.
Pharmaceutical statistics 2012;11(5):351-6.
2012: Alexander H G Paterson; Edith A Perez; Andre Robidoux; Sandra M Swain; Lorna M Weir; Ping Zheng; Stewart J Anderson; Luis Baez-Diaz; Adam M Brufsky; Joseph P Costantino; Shaker Dakhil; Carla I Falkson; Louis Fehrenbacher; Charles E Geyer; Julie R Gralow; Karen M King; Thomas Lad; Barry C Lembersky; Eleftherios P Mamounas; Norman Wolmark
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.
The lancet oncology 2012;13(7):734-42.
2012: Reena S Cecchini; Joseph P Costantino; Walter M Cronin; Stephanie R Land; Joel L Weissfeld; D Lawrence Wickerham; Jane A Cauley; Norman Wolmark
Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.
Cancer prevention research (Philadelphia, Pa.) 2012;5(4):583-92.
2012: Harry D Bear; Adam M Brufsky; Joseph P Costantino; Louis Fehrenbacher; Rakesh Gaur; Charles E Geyer; Howard M Gross; Eleftherios P Mamounas; Richard G Margolese; Rita S Mehta; Priya Rastogi; Andre Robidoux; Francis M Senecal; Sandra M Swain; Gong Tang; Paul T Adams; James N Atkins; Luis Baez-Diaz; James A Young; Norman Wolmark
Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
The New England journal of medicine 2012;366(4):310-20.
2011: Carolyn D Runowicz; Victor Vogel; D Lawrence Wickerham; Reena S Cecchini; Joseph P Costantino; Walter M Cronin; Leslie G Ford; Norman Wolmark
Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).
American journal of obstetrics and gynecology 2011;205(6):535.e1-5.
2011: Gong Tang; Joseph P Costantino; Michael Crager; Jack Cuzick; Mitch Dowsett; John F Forbes; Eleftherios P Mamounas; Steven Shak; Norman Wolmark
Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(33):4365-72.
2011: Chungyeul Kim; Ahwon Lee; Worta McCaskill-Stevens; Frederick L Baehner; Joffre Baker; Olga L Bohn; Joseph P Costantino; Maureen T Cronin; Leslie G Ford; Debora Fumagalli; Charles E Geyer; Katherine L Pogue-Geile; Megan L Reilly; Steven Shak; Gong Tang; Yusuke Taniyama; Victor G Vogel; Drew Watson; D Lawrence Wickerham; Norman Wolmark; Soonmyung Paik
Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(31):4160-7.
2011: Stephanie R Land; D Lawrence Wickerham; William M P Klein; Nicholas J Christian; Joseph P Costantino; Walter M Cronin; Patricia A Ganz
Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.
Cancer prevention research (Philadelphia, Pa.) 2011;4(9):1393-400.
2011: Rayna K Matsuno; David Pee; Regina G Ziegler; Garnet L Anderson; Joseph P Costantino; Huilin Li; Mitchell H Gail
Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.
Journal of the National Cancer Institute 2011;103(12):951-61.
2011: Andrew N Freedman; Mitchell H Gail; Barry I Graubard; Garnet L Anderson; Joseph P Costantino; Victor G Vogel; Binbing Yu; Worta McCaskill-Stevens
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(17):2327-33.
2011: Gong Tang; Steven Shak; Soonmyung Paik; Stewart J Anderson; Joseph P Costantino; Charles E Geyer; Eleftherios P Mamounas; D Lawrence Wickerham; Norman Wolmark
Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
Breast cancer research and treatment 2011;127(1):133-42.
2011: Patricia Anne Ganz; Stephanie R Land; Charles E Geyer; Reena S Cecchini; Joseph P Costantino; Eduardo R Pajon; Louis Fehrenbacher; James N Atkins; Jonathan A Polikoff; Victor Vogel; John K Erban; Robert B Livingston; Edith A Perez; Eleftherios P Mamounas; Norman Wolmark; Sandra M Swain
Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(9):1110-6.
2010: David N Krag; Stewart J Anderson; Thomas B Julian; Ann M Brown; Seth P Harlow; Joseph P Costantino; Takamaru Ashikaga; Donald L Weaver; Eleftherios P Mamounas; Lynne M Jalovec; Thomas G Frazier; R Dirk Noyes; Andre Robidoux; Hugh Mc Scarth; Norman Wolmark
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
The lancet oncology 2010;11(10):927-33.
2010: Stephanie R Land; Jacek A Kopec; Thomas B Julian; Ann M Brown; Stewart J Anderson; David N Krag; Nicholas J Christian; Joseph P Costantino; Norman Wolmark; Patricia Anne Ganz
Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(25):3929-36.
2010: Takamaru Ashikaga; David N Krag; Stephanie R Land; Thomas B Julian; Stewart J Anderson; Ann M Brown; Joan M Skelly; Seth P Harlow; Donald L Weaver; Eleftherios P Mamounas; Joseph P Costantino; Norman Wolmark
Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.
Journal of surgical oncology 2010;102(2):111-8.
2010: Sherry X Yang; Joseph P Costantino; Chungyeul Kim; Eleftherios P Mamounas; Dat Nguyen; Jong-Hyeon Jeong; Norman Wolmark; Kelley M Kidwell; Soonmyung Paik; Sandra M Swain
Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(18):2974-81.
2010: Sandra M Swain; Jong-Hyeon Jeong; Charles E Geyer; Joseph P Costantino; Eduardo R Pajon; Louis Fehrenbacher; James N Atkins; Jonathan Polikoff; Victor Vogel; John K Erban; Priya Rastogi; Robert B Livingston; Edith A Perez; Eleftherios P Mamounas; Stephanie R Land; Patricia Anne Ganz; Norman Wolmark
Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.
The New England journal of medicine 2010;362(22):2053-65.
2010: Victor Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Carolyn D Runowicz; Patricia Anne Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Cancer prevention research (Philadelphia, Pa.) 2010;3(6):696-706.
2010: Norman Wolmark; Walter J. CURRAN; Frank Vicini; Julia White; Joseph P Costantino; Douglas Arthur; Robert Kuske; Rachel Rabinovitch; Thomas B Julian; David S Parda
Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" Int J Radiat Oncol Biol Phys 2009;75:1290-1296).
International journal of radiation oncology, biology, physics 2010;77(1):317; author reply 318.
2010: Neal W Wilkinson; Greg Yothers; Samia Lopa; Joseph P Costantino; Nicholas J Petrelli; Norman Wolmark
Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials.
Annals of surgical oncology 2010;17(4):959-66.
2010: Eleftherios P Mamounas; Gong Tang; Bernard Fisher; Soonmyung Paik; Steven Shak; Joseph P Costantino; Drew Watson; Charles E Geyer; D Lawrence Wickerham; Norman Wolmark
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1677-83.
2010: Jennifer Eng-Wong; Joseph P Costantino; Sandra M Swain
The impact of systemic therapy following ductal carcinoma in situ.
Journal of the National Cancer Institute. Monographs 2010;2010(41):200-3.
2010: Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Worta McCaskill-Stevens; Richard B Clarfeld; Michael D Grant; Norman Wolmark
Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials.
Journal of the National Cancer Institute. Monographs 2010;2010(41):181-6.
2009: Stewart J Anderson; Irene Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Jong-Hyeon Jeong; Charles E Geyer; D Lawrence Wickerham; Joseph P Costantino; Norman Wolmark
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(15):2466-73.
2009: D Lawrence Wickerham; Joseph P Costantino; Victor Vogel; Walter M Cronin; Reena S Cecchini; Leslie G Ford; Norman Wolmark
The use of tamoxifen and raloxifene for the prevention of breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2009;181():113-9.
2009: Sandra M Swain; Stephanie R Land; Marcie W Ritter; Joseph P Costantino; Reena S Cecchini; Eleftherios P Mamounas; Norman Wolmark; Patricia Anne Ganz
Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
Breast cancer research and treatment 2009;113(2):315-20.
2008: D Lawrence Wickerham; Michael J O'Connell; Joseph P Costantino; Walter M Cronin; Soonmyung Paik; Charles E Geyer; Patricia Anne Ganz; Nicholas Petrelli; Eleftherios P Mamounas; Thomas B Julian; Norman Wolmark
The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project.
Seminars in oncology 2008;35(5):522-9.
2008: Irene L Wapnir; Stefan Aebi; Charles E Geyer; David Zahrieh; Richard D Gelber; Stewart J Anderson; Andre Robidoux; Jürg Bernhard; Rudolf Maibach; Monica Castiglione-Gertsch; Alan Coates; Martine J Piccart; Mark J Clemons; Joseph P Costantino; Norman Wolmark
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.
Clinical breast cancer 2008;8(3):287-92.
2008: David Cella; Stephanie R Land; Chih-Hung Chang; Richard Day; Joseph P Costantino; Norman Wolmark; Patricia Anne Ganz
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.
Breast cancer research and treatment 2008;109(3):515-26.
2008: Jong-Hyeon Jeong; Sin-Ho Jung; Joseph P Costantino
Nonparametric inference on median residual life function.
Biometrics 2008;64(1):157-63.
2007: Mitchell H Gail; Joseph P Costantino; David Pee; Melissa L Bondy; Lisa A Newman; Mano Selvan; Garnet L Anderson; Kathleen E Malone; Polly A Marchbanks; Worta McCaskill-Stevens; Sandra A Norman; Michael Steven Simon; Robert Spirtas; Giske Ursin; Leslie Bernstein
Projecting individualized absolute invasive breast cancer risk in African American women.
Journal of the National Cancer Institute 2007;99(23):1782-92.
2007: Stephanie R Land; Marcie W Ritter; Joseph P Costantino; Thomas B Julian; Walter M Cronin; Sarah R Haile; Norman Wolmark; Patricia Anne Ganz
Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(32):5113-20.
2007: Edwin R Fisher; Joseph P Costantino; Marino Enrique Leon; Hanna Bandos; Alka S Palekar; Bernard Fisher; Norman Wolmark
Pathobiology of small invasive breast cancers without metastases (T1a/b, N0, M0): National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-21.
Cancer 2007;110(9):1929-36.
2007: David N Krag; Stewart J Anderson; Thomas B Julian; Ann M Brown; Seth P Harlow; Takamaru Ashikaga; Donald L Weaver; Barbara J Miller; Lynne M Jalovec; Thomas G Frazier; R Dirk Noyes; Andre Robidoux; Hugh M C Scarth; Denise M. Mammolito; David R McCready; Eleftherios P Mamounas; Joseph P Costantino; Norman Wolmark
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.
The lancet oncology 2007;8(10):881-8.
2007: Thomas B Julian; Stephanie R Land; Virginie Fourchotte; Sarah R Haile; Edwin R Fisher; Eleftherios P Mamounas; Joseph P Costantino; Norman Wolmark
Is sentinel node biopsy necessary in conservatively treated DCIS?
Annals of surgical oncology 2007;14(8):2202-8.
2007: Edwin R Fisher; Stephanie R Land; Reda S Saad; Bernard Fisher; D Lawrence Wickerham; Meihua Wang; Joseph P Costantino; Norman Wolmark
Pathologic variables predictive of breast events in patients with ductal carcinoma in situ.
American journal of clinical pathology 2007;128(1):86-91.
2007: Stephanie R Land; Jacek A Kopec; Reena S Cecchini; Patricia Anne Ganz; H Samuel Wieand; Linda H Colangelo; Kate Murphy; J Philip Kuebler; Thomas E Seay; Burton M Needles; James Bearden; Lauren K Colman; Keith S Lanier; Eduardo R Pajon; David Cella; Roy E Smith; Michael J O'Connell; Joseph P Costantino; Norman Wolmark
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2205-11.
2006: Eleftherios P Mamounas; Barry C Lembersky; Jong-Hyeon Jeong; Walter M Cronin; Barbara Harkins; Charles E Geyer; D Lawrence Wickerham; Soonmyung Paik; Joseph P Costantino; Norman Wolmark
NSABP B-42: a clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging disease-free survival in postmenopausal women with hormone receptor-positive breast cancer.
Clinical breast cancer 2006;7(5):416-21.
2006: Alphonse G Taghian; Jong-Hyeon Jeong; Eleftherios P Mamounas; David S Parda; Melvin Deutsch; Joseph P Costantino; Norman Wolmark
Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3927-32.
2006: Soonmyung Paik; Gong Tang; Steven Shak; Chungyeul Kim; Joffre Baker; Wanseop Kim; Maureen Cronin; Frederick L Baehner; Drew Watson; John Bryant; Joseph P Costantino; Charles E Geyer; D Lawrence Wickerham; Norman Wolmark
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(23):3726-34.
2006: Aiman El-Saed; Lewis H Kuller; Anne B Newman; Oscar L Lopez; Joseph P Costantino; Kathleen McTigue; Mary Cushman; Richard A Kronmal
Geographic variations in stroke incidence and mortality among older populations in four US communities.
Stroke; a journal of cerebral circulation 2006;37(8):1975-9.
2006: Aiman El-Saed; Lewis H Kuller; Anne B Newman; Oscar L Lopez; Joseph P Costantino; Kathleen McTigue; Mary Cushman; Richard A Kronmal
Factors associated with geographic variations in stroke incidence among older populations in four US communities.
Stroke; a journal of cerebral circulation 2006;37(8):1980-5.
2006: Norman S Abramson; Joseph P Costantino; Judy E Garber; Nancy Berliner; D Lawrence Wickerham; Norman Wolmark
Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Journal of the National Cancer Institute 2006;98(13):904-10.
2006: D Lawrence Wickerham; Joseph P Costantino; Eleftherios P Mamounas; Thomas B Julian
The landmark surgical trials of the National Surgical Adjuvant Breast and Bowel Project.
World journal of surgery 2006;30(7):1138-46.
2006: Stephanie R Land; D Lawrence Wickerham; Joseph P Costantino; Marcie W Ritter; Victor Vogel; Myoungkeun Lee; Eduardo R Pajon; James L Wade Iii; Shaker R Dakhil; James B Lockhart; Norman Wolmark; Patricia Anne Ganz
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
JAMA : the journal of the American Medical Association 2006;295(23):2742-51.
2006: Victor Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade Iii; Andre Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia Anne Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
JAMA : the journal of the American Medical Association 2006;295(23):2727-41.
2006: Francesmary Modugno; Duyen L Ngo; Glenn O Allen; Lewis H Kuller; Roberta B Ness; Victor Vogel; Joseph P Costantino; Jane A Cauley
Breast cancer risk factors and mammographic breast density in women over age 70.
Breast cancer research and treatment 2006;97(2):157-66.
2006: Jong-Hyeon Jeong; Joseph P Costantino
Application of smoothing methods to evaluate treatment-prognostic factor interactions in breast cancer data.
Cancer investigation 2006;24(3):288-93.
2006: Mary Beattie; Joseph P Costantino; Steven R Cummings; D Lawrence Wickerham; Victor Vogel; Mitch Dowsett; Elizabeth Folkerd; Walter C Willett; Norman Wolmark; Susan E Hankinson
Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Journal of the National Cancer Institute 2006;98(2):110-5.
2005: Bernard Fisher; Joseph P Costantino; D Lawrence Wickerham; Reena S Cecchini; Walter M Cronin; Andre Robidoux; Therese B Bevers; Maureen T Kavanah; James N Atkins; Richard G Margolese; Carolyn D Runowicz; Joan M James; Leslie G Ford; Norman Wolmark
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Journal of the National Cancer Institute 2005;97(22):1652-62.
2005: Michael B Gorin; Joseph P Costantino; Destan N Kulacoglu; F Yesim K Demirci; D Lawrence Wickerham; Bernard Fisher; Norman Wolmark
Is tamoxifen a risk factor for retinal vaso-occlusive disease?
Retina (Philadelphia, Pa.) 2005;25(4):523-6.
2005: Eva Chalas; Joseph P Costantino; D Lawrence Wickerham; Norman Wolmark; George C Lewis; Cynthia Bergman; Carolyn D Runowicz
Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.
American journal of obstetrics and gynecology 2005;192(4):1230-7; discussion 1237-9.
2004: Jiping Wang; Joseph P Costantino; Elizabeth Tan-Chiu; D Lawrence Wickerham; Soonmyung Paik; Norman Wolmark
Lower-category benign breast disease and the risk of invasive breast cancer.
Journal of the National Cancer Institute 2004;96(8):616-20.
2004: Patricia K Agatisa; Roberta B Ness; James M Roberts; Joseph P Costantino; Lewis H Kuller; Margaret K McLaughlin
Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk.
American journal of physiology. Heart and circulatory physiology 2004;286(4):H1389-93.
2003: Henry E Wang; Douglas F Kupas; Paul M Paris; Robyn R Bates; Joseph P Costantino; Donald M Yealy
Multivariate predictors of failed prehospital endotracheal intubation.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2003;10(7):717-24.
2003: Elizabeth Tan-Chiu; Jiping Wang; Joseph P Costantino; Soonmyung Paik; Cheryl Butch; D Lawrence Wickerham; Bernard Fisher; Norman Wolmark
Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.
Journal of the National Cancer Institute 2003;95(4):302-7.
2003: Victor Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin
National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):495S-501S.
2003: Mary Cushman; Joseph P Costantino; Edwin G Bovill; D Lawrence Wickerham; Lenore Buckley; John D Roberts; David N Krag
Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial.
British journal of haematology 2003;120(1):109-16.
2002: Victor Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin
Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
Journal of the National Cancer Institute 2002;94(19):1504.
2002: Victor Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Norman Wolmark
The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.
Clinical breast cancer 2002;3(2):153-9.
2002: D Lawrence Wickerham; Bernard Fisher; Norman Wolmark; John Bryant; Joseph P Costantino; Leslie Bernstein; Carolyn D Runowicz
Association of tamoxifen and uterine sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2758-60.
2002: Joseph P Costantino
The impact of hormonal treatments on quality of life of patients with metastatic breast cancer.
Clinical therapeutics 2002;24 Suppl C():C26-42.
2001: Barbara K Dunn; M Anthony; S Sherman; Joseph P Costantino
Conclusions: Considerations regarding SERMs.
Annals of the New York Academy of Sciences 2001;949():352-65.
2001: Joseph P Costantino
Benefit/risk assessment of SERM therapy: clinical trial versus clinical practice settings.
Annals of the New York Academy of Sciences 2001;949():280-5.
2001: Mary-Claire King; Samuel Wieand; K Hale; M Lee; Tom Walsh; K Owens; J Tait; L Ford; B K Dunn; Joseph P Costantino; Lawrence Wickerham; Norman Wolmark; B Fisher
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.
JAMA : the journal of the American Medical Association 2001;286(18):2251-6.
2001: R Day; Patricia Anne Ganz; Joseph P Costantino
Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study.
Journal of the National Cancer Institute 2001;93(21):1615-23.
2001: Joseph P Costantino; Victor Vogel
Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials: an alternative view.
Clinical breast cancer 2001;2(1):41-6.
2001: Mary Cushman; Joseph P Costantino; Russell P Tracy; K Song; L Buckley; J D Roberts; David N Krag
Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(2):255-61.
2001: Steven E Reis; Joseph P Costantino; D Lawrence Wickerham; Elizabeth Tan-Chiu; Jiping Wang; Maureen T Kavanah
Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.
Journal of the National Cancer Institute 2001;93(1):16-21.
2000: Mitchell H Gail; Joseph P Costantino; John Bryant; Robert T Croyle; Laurence Freedman; Kathy J Helzlsouer; V Vogel
Re: Risk/benefit assessment of tamoxifen to prevent breast cancer-still a work in progress?
Journal of the National Cancer Institute 2000;92(7):574-5.
1999: Mitchell H Gail; Joseph P Costantino; John Bryant; Robert T Croyle; Laurence Freedman; Kathy J Helzlsouer; V Vogel
Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
Journal of the National Cancer Institute 1999;91(21):1829-46.
1999: Joseph P Costantino; Mitchell H Gail; David Pee; Steve Anderson; CK Redmond; Jacques Benichou; H Samuel Wieand
Validation studies for models projecting the risk of invasive and total breast cancer incidence.
Journal of the National Cancer Institute 1999;91(18):1541-8.
1999: R Day; Patricia Anne Ganz; Joseph P Costantino; Walter M Cronin; D Lawrence Wickerham; Bernard Fisher
Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2659-69.
1999: Edwin R Fisher; James J Dignam; Elizabeth Tan-Chiu; Joseph P Costantino; Bernard Fisher; Soonmyung Paik; Norman Wolmark
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.
Cancer 1999;86(3):429-38.
1999: Vincent C Arena; Joseph P Costantino; Nancy Sussman; CK Redmond
Issues and findings in the evaluation of occupational risk among women high nickel alloys workers.
American journal of industrial medicine 1999;36(1):114-21.
1998: Vincent C Arena; Nancy Sussman; CK Redmond; Joseph P Costantino; Jeanette M Trauth
Using alternative comparison populations to assess occupation-related mortality risk. Results for the high nickel alloys workers cohort.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 1998;40(10):907-16.
1998: Bernard Fisher; Joseph P Costantino; D Lawrence Wickerham; CK Redmond; Maureen T Kavanah; Walter M Cronin; V Vogel; Andre Robidoux; NV Dimitrov; J Atkins; M Daly; Samuel Wieand; Elizabeth Tan-Chiu; L Ford; Norman Wolmark
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
Journal of the National Cancer Institute 1998;90(18):1371-88.
1998: Michael B Gorin; R Day; Joseph P Costantino; Bernard Fisher; CK Redmond; Lawrence Wickerham; J E Gomolin; Richard G Margolese; M K Mathen; D M Bowman; D I Kaufman; NV Dimitrov; L J Singerman; R Bornstein; Norman Wolmark; D Kaufmann
Long-term tamoxifen citrate use and potential ocular toxicity.
American journal of ophthalmology 1998;125(4):493-501.
1998: Bernard Fisher; James J Dignam; Norman Wolmark; Eleftherios P Mamounas; Joseph P Costantino; W Poller; Edwin R Fisher; D Lawrence Wickerham; Melvin Deutsch; Richard G Margolese; NV Dimitrov; Maureen T Kavanah
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):441-52.
1998: John Bryant; Bernard Fisher; N Gündüz; Joseph P Costantino; B Emir
S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer.
Breast cancer research and treatment 1998;51(3):239-53.
1997: James J Dignam; CK Redmond; Bernard Fisher; Joseph P Costantino; B K Edwards
Prognosis among African-American women and white women with lymph node negative breast carcinoma: findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).
Cancer 1997;80(1):80-90.
1997: Joseph P Costantino; Lewis H Kuller; Diane G Ives; Bernard Fisher; James J Dignam
Coronary heart disease mortality and adjuvant tamoxifen therapy.
Journal of the National Cancer Institute 1997;89(11):776-82.
1996: Patrick J Strollo; Mark H Sanders; Joseph P Costantino; S K Walsh; R A Stiller; Charles W Atwood
Split-night studies for the diagnosis and treatment of sleep-disordered breathing.
Sleep 1996;19(10 Suppl):S255-9.
1996: Bernard Fisher; James J Dignam; John Bryant; Arthur DeCillis; D Lawrence Wickerham; Norman Wolmark; Joseph P Costantino; C Redmond; Edwin R Fisher; D M Bowman; L Deschênes; NV Dimitrov; Richard G Margolese; Andre Robidoux; H Shibata; J Terz; A H Paterson; M I Feldman; W Farrar; J Evans; H L Lickley
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.
Journal of the National Cancer Institute 1996;88(21):1529-42.
1996: Edwin R Fisher; Joseph P Costantino; Bernard Fisher; A S Palekar; S M Paik; C M Suarez; Norman Wolmark
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
Cancer 1996;78(7):1403-16.
1996: Bernard Fisher; James J Dignam; Eleftherios P Mamounas; Joseph P Costantino; D Lawrence Wickerham; C Redmond; Norman Wolmark; NV Dimitrov; D M Bowman; Andrew G. Glass; James N Atkins; Norman S Abramson; C M Sutherland; B S Aron; Richard G Margolese
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(7):1982-92.
1996: CK Redmond; Joseph P Costantino
Design and current status of the NSABP breast cancer prevention trial.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():309-17.
1995: S J Anderson; Joseph P Costantino; A M Brown; J L Bryant; Walter M Cronin; James J Dignam; J M Jones; H E Rockette; Samuel Wieand
Breast cancer trials on trial: a case of conflicting ethical interests.
Cancer 1995;76(7):1294-5.
1995: Joseph P Costantino; CK Redmond; A Bearden
Occupationally related cancer risk among coke oven workers: 30 years of follow-up.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 1995;37(5):597-604.
1995: Edwin R Fisher; Joseph P Costantino; Bernard Fisher; A S Palekar; C Redmond; Eleftherios P Mamounas
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators.
Cancer 1995;75(6):1310-9.
1994: Edwin R Fisher; Joseph P Costantino
Quality assurance of pathology in clinical trials. The National Surgical Adjuvant Breast and Bowel Project experience.
Cancer 1994;74(9 Suppl):2638-41.
1994: Mark H Sanders; N B Kern; Joseph P Costantino; R A Stiller; Patrick J Strollo; K A Studnicki; J A Coates; T J Richards
Accuracy of end-tidal and transcutaneous PCO2 monitoring during sleep.
Chest 1994;106(2):472-83.
1994: Bernard Fisher; Joseph P Costantino; CK Redmond; Edwin R Fisher; D Lawrence Wickerham; Walter M Cronin
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
Journal of the National Cancer Institute 1994;86(7):527-37.
1993: Mark H Sanders; N B Kern; Joseph P Costantino; R A Stiller; K Studnicki; J Coates; S Orris; S Schimerman
Prescription of positive airway pressure for sleep apnea on the basis of a partial-night trial.
Sleep 1993;16(8 Suppl):S106-7.
1993: Bernard Fisher; Joseph P Costantino; C Redmond; E Fisher; Richard G Margolese; NV Dimitrov; Norman Wolmark; D Lawrence Wickerham; Melvin Deutsch; Liora Ore
Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.
The New England journal of medicine 1993;328(22):1581-6.
1993: Mark H Sanders; N B Kern; Joseph P Costantino; R A Stiller; K Studnicki; J Coates; S Orris; S Schimerman
Adequacy of prescribing positive airway pressure therapy by mask for sleep apnea on the basis of a partial-night trial.
The American review of respiratory disease 1993;147(5):1169-74.
1993: Edwin R Fisher; Joseph P Costantino; Bernard Fisher; C Redmond
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project Investigators.
Cancer 1993;71(6 Suppl):2141-50.
1992: Robert M Rogers; Michael P Donahoe; Joseph P Costantino
Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study.
The American review of respiratory disease 1992;146(6):1511-7.
1991: Mark H Sanders; J Black; Joseph P Costantino; N Kern; K Studnicki; J Coates
Diagnosis of sleep-disordered breathing by half-night polysomnography.
The American review of respiratory disease 1991;144(6):1256-61.
1991: Bernard Fisher; N Gunduz; Joseph P Costantino; Edwin R Fisher; C Redmond; Eleftherios P Mamounas; R Siderits
DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
Cancer 1991;68(7):1465-75.
1991: Frank C Sciurba; G R Owens; Mark H Sanders; Joseph P Costantino; I L Paradis; Bartley P Griffith
The effect of obliterative bronchiolitis on breathing pattern during exercise in recipients of heart-lung transplants.
The American review of respiratory disease 1991;144(1):131-5.
1991: S Y Zhou; Sati Mazumdar; CK Redmond; M H Dong; Joseph P Costantino
Computations of adjusted rates and lifetime risks from occupational cohort data: a program package using FORTRAN and GLIM.
Computers and biomedical research, an international journal 1991;24(1):29-46.
1991: Sati Mazumdar; CK Redmond; Joseph P Costantino; R N Patwardhan; S Y Zhou
Recent developments in the multistage modeling of cohort data for carcinogenic risk assessment.
Environmental health perspectives 1991;90():271-7.
1990: M Pollak; Joseph P Costantino; Constantin Polychronakos; S A Blauer; H Guyda; C Redmond; B Fisher; Richard G Margolese
Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients.
Journal of the National Cancer Institute 1990;82(21):1693-7.
1990: J L Werchowski; Mark H Sanders; Joseph P Costantino; Frank C Sciurba; Robert M Rogers
Inductance plethysmography measurement of CPAP-induced changes in end-expiratory lung volume.
Journal of applied physiology (Bethesda, Md. : 1985) 1990;68(4):1732-8.
1990: Mark H Sanders; Joseph P Costantino; Jonas T Johnson
Polysomnography early after uvulopalatopharyngoplasty as a predictor of late postoperative results.
Chest 1990;97(4):913-9.
1989: Sati Mazumdar; CK Redmond; P E Enterline; Gary M Marsh; Joseph P Costantino; S Y Zhou; R N Patwardhan
Multistage modeling of lung cancer mortality among arsenic-exposed copper-smelter workers.
Risk analysis : an official publication of the Society for Risk Analysis 1989;9(4):551-63.
1989: Mark H Sanders; Joseph P Costantino; G R Owens; Frank C Sciurba; Robert M Rogers; Charles F Reynolds; I L Paradis; Bartley P Griffith; R L Hardesty
Breathing during wakefulness and sleep after human heart-lung transplantation.
The American review of respiratory disease 1989;140(1):45-51.
1989: Bernard Fisher; Joseph P Costantino; C Redmond; R Poisson; D Bowman; J Couture; NV Dimitrov; Norman Wolmark; D Lawrence Wickerham; Edwin R Fisher
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.
The New England journal of medicine 1989;320(8):479-84.
1988: Frank C Sciurba; G R Owens; Mark H Sanders; Bartley P Griffith; R L Hardesty; I L Paradis; Joseph P Costantino
Evidence of an altered pattern of breathing during exercise in recipients of heart-lung transplants.
The New England journal of medicine 1988;319(18):1186-92.
1988: Joseph P Costantino; Lewis H Kuller; L Begg; CK Redmond; M W Bates
Serum level changes after administration of a pharmacologic dose of beta-carotene.
The American journal of clinical nutrition 1988;48(5):1277-83.
1988: M H Dong; CK Redmond; Sati Mazumdar; Joseph P Costantino
A multistage approach to the cohort analysis of lifetime lung cancer risk among steelworkers exposed to coke oven emissions.
American journal of epidemiology 1988;128(4):860-73.
1988: M A Bender; R C Leonard; O White; Joseph P Costantino; CK Redmond
Chromosomal aberrations and sister-chromatid exchanges in lymphocytes from coke oven workers.
Mutation research 1988;206(1):11-6.